Hématologie is the official organ of the French Society of Hematology. It publishes review articles in all areas of hematology, written by the best specialists in these fields. These reviews are generally solicited by members of the editorial board, but direct submissions are welcome. Regardless of the mode of submission, manuscripts are peer-reviewed and revisions are, in most cases, requested before publication. The journal also provides a forum for interns and junior faculty to comment on recent major publications or papers from international haematology meetings. The journal also publishes the proceedings of the annual meeting of the French Society of Hematology. Articles may be submitted in French or English.

It is intended for hematologists, as well as students in training (DES, AFSA, etc.). It covers all hematological diseases, both malignant and benign. Hématologie (Éditions John Libbey Eurotext) publishes, in French or in English, reviews, anatomical cases, forums for ethical reflection, recommendations from learned societies and cooperative groups, as well as short reports on current literature in haematology. It also features "Residents' Corner" and "How I treat", which give the floor to hematology residents and senior specialists respectively. Articles are most often solicited by the editorial staff, but any proposal for collaboration will be considered with interest.


Ahead of print

English e-section of Hématologie

Breast implant-associated anaplastic large-cell lymphoma: from diagnosis to molecular sequencing
Camille Laurent, Corinne Haioun, Philippe Gaulard
Online since 13/05/2021

Myeloma before the age of 40: a French retrospective studyRunning title: Myeloma before the age of 40
Alexis Caulier, Bruno Royer
Online since 16/02/2022

The immune microenvironment and immunotherapy of multiple myeloma
Nicolas Gazeau, Salomon Manier
Online since 01/02/2022

Hereditary afibrinogenaemia: from genetics to treatments
Alessandro Casini, Françoise Bridey, Philippe de Moerloose
Online since 24/02/2022

Prognostic factors in diffuse large B-cell lymphoma at diagnosis (excluding the International Prognostic Index)
Julien Calvani, Véronique Meignin, Laëtitia Vercellino, Catherine Thieblemont
Online since 24/02/2022

Indications and procedure for CAR T-cell infusion
Jérôme Paillassa, Catherine Thieblemont
Online since 24/02/2022

Optimising the evaluation of therapeutic response to first-line treatment of diffuse large B cell lymphoma
Fabrice Jardin
Online since 16/02/2022

Mechanisms of resistance to targeted therapies
Romain Guièze
Online since 16/02/2022

Pre-therapeutic assessment of chronic lymphocytic leukaemia: what are the genetic tests and why?
Fanny Baran-Marszak
Online since 01/02/2022

Developments in thrombotic thrombocytopenic purpura and ADAMTS13
Bérangère Joly, Nicolas Beranger, Ygal Benhamou, Paul Coppo, Agnès Veyradier
Online since 23/12/2021

The genomic landscape of adult B-cell precursor acute lymphoblastic leukaemia
Marie Passet, Ibrahima Ba, Emmanuelle Clappier
Online since 17/10/2020

Congenital factor XIII deficiency: diagnosis, prevalence and treatment modalities in 2020
Lucia Rugeri, Séverine Bouttefroy, Émilie Jousselme, Christophe Nougier, Sandrine Meunier
Online since 30/10/2020

End-of-life platelet transfusion in haematological malignancies: a review
Julie Moracchini, Audrey Seigeot, Étienne Daguindau, Aurélie Godard-Marceau, Régis Aubry, Sandra Frache
Online since 30/10/2020

Personalised treatment for haemophilia
Yesim Dargaud
Online since 30/10/2020

Occupational exposure and risk of lymphomas
Jérôme Paillassa, Audrey Petit
Online since 06/11/2020

Next-generation sequencing in patients with hairy cell leukaemia (HCL)
Margaux Wiber, Elsa Maitre, Xavier Troussard
Online since 14/10/2020

New molecular classifications of diffuse large-cell lymphomas
Fabrice Jardin
Online since 02/10/2020

Germline RUNX1 mutations/deletions and genetic predisposition to haematological malignancies
Iléana Antony-Debré, Nicolas Duployez
Online since 30/09/2021

Pathophysiology and abnormalities of haemostasis in intensive care patients with COVID-19
Bérangère Joly, Nicolas Béranger, Maxime Delrue, Marie Neuwirth, Nathalie Itzhar-Baïkian, Arezki Hadj-Ali, Alain Stepanian, Agnes Veyradier, Virginie Siguret
Online since 07/10/2021

Sickle cell disease and the risk of malignant haemopathies
Françoise Bernaudin, Mathieu Kuentz, Yves Beuzard
Online since 16/01/2022

Enhancers, spatial chromosome structuring and pathological changes: towards a better understanding of complex genome alterations
Éric Soler
Online since 23/12/2021

Haemoglobin and haemoglobinopathies at the forefront of the 21st century
Yves Beuzard
Online since 23/12/2021

Wiskott-Aldrich syndrome
Isabelle Pellier, Charline Miot, Nizar Mahlaoui, Alain Fischer
Online since 23/12/2021

Neutrophil extracellular traps: key drivers of severe COVID-19
Cécile Oury, Thomas Marichal
Online since 16/01/2022

Sialylation and thrombocytopenia
Dominique Lasne, Delphine Borgel, Alexandre Kauskot
Online since 17/12/2020

Biological aspects of minimal residual disease in acute leukaemia
Claude Preudhomme, Adriana Plesa, Christophe Roumier
Online since 24/03/2021

Actualités cliniques


DA-EPOCH-R ou le choix d’une première ligne thérapeutique plus intensive pour les lymphomes B diffus à grandes cellules single- ou double-hit
Laura Herbreteau, Jean-Christophe Ianotto, Adrian Tempescul
Online since 08/03/2019